Implant can detect organ rejection weeks in advance.
Implant can detect organ rejection weeks in advance.
New Implant Offers Early Warning of Organ Rejection
![Organ Transplant](https://consumer.healthday.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8zNjM1OTI2MC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzUxMDY0N30.0q-3WHafONX4Ng4kw0zReSFt0Wdby93eRiJOqdglVwk/image.jpg)
Receiving an organ transplant can be a nerve-wracking, yet lifesaving, experience. Dr. Joaquin Brieva, a dermatologist at Northwestern Medicine in Evanston, Illinois, and a kidney transplant recipient, recalls the anxiety that comes with the constant concern of kidney rejection. However, an experimental implant currently being tested could potentially alleviate some of that anxiety by providing early warnings of organ rejection.
The ultrathin soft implant, which sits directly on a transplanted kidney, has the ability to detect temperature changes associated with transplant rejection. This tiny, paper-thin device can send wireless alerts to a nearby smartphone or tablet, indicating that a transplant recipient may be at risk of rejection. Researchers have demonstrated that the implant can detect warning signs of rejection up to three weeks earlier than current monitoring methods, providing physicians with an opportunity to intervene sooner and prevent organ rejection.
For the approximately 250,000 people in the United States living with a transplanted kidney, the journey of monitoring their organ’s health is a constant concern. Transplant rejection can occur at any time, either immediately after the transplant or years later, and it is often silent, without any noticeable symptoms. This uncertainty can cause persistent anxiety for transplant recipients, impacting their peace of mind and overall well-being.
The current methods of monitoring kidney health involve blood tests and biopsies. However, blood tests can be inconclusive, as the standard biomarkers can fluctuate for reasons unrelated to organ rejection. On the other hand, biopsy procedures are invasive and can carry multiple risks, including bleeding, infection, pain, and damage to nearby tissues. Moreover, waiting for biopsy results can be time-consuming, potentially delaying critical decisions regarding patient care.
To address these challenges, researchers at Northwestern University have developed a bioelectronic implant that monitors the temperature of transplanted organs. Inflammation typically leads to temperature increases, making unusual temperature changes a potential early warning sign of transplant rejection. In an animal study, researchers found that the local temperature of a transplanted kidney increased just before rejection events. This increase was detected two to three days earlier than changes observed in blood tests for animals without immunosuppressant medications, and even earlier for those with medication.
- Company removes ‘One Chip Challenge’ from stores follow...
- Two-step test improves accuracy of Alzheimer’s disease screen...
- After semaglutide treatment, newly diagnosed type 1 diabetes patien...
The implant is small enough to fit below the fibrous layer called the renal capsule that covers the kidney. It contains a highly sensitive thermometer connected to a miniature coin cell battery and other electronic components. The device rests securely against the kidney, maintaining good thermal contact with the organ. The implant’s continuous, real-time monitoring provides a level of reassurance for transplant recipients.
Dr. Lorenzo Gallon, a Northwestern Medicine transplant nephrologist and the clinical lead researcher, explains that the device could alleviate patients’ constant anxiety about the health of their transplanted organ. The implant offers the potential for continuous monitoring, ensuring any sudden changes in the kidney transplant are promptly detected, even before any clinical warning signs arise.
While the current study focused specifically on kidney transplants, the researchers believe that a similar implant could be used for other organ transplants, such as the liver and lungs. The implant’s ability to monitor the patient’s transplanted organ in real-time is a critical step towards personalized dosing and medicine, as each individual responds differently to anti-rejection therapy.
The Northwestern research team is now conducting further tests using larger animal models. They are also exploring ways to recharge the coin cell battery so that it can last a lifetime. The potential benefits of this implant are substantial, offering transplant recipients greater peace of mind and reducing the risk of organ rejection. Early detection and intervention can significantly improve the long-term health outcomes of organ transplant recipients.
Organ transplant recipients like Dr. Brieva find hope in this new implant. The early detection capabilities of the device could provide life-saving interventions and eliminate the constant fear of rejection. The ability to monitor the health of a transplanted organ in real-time offers reassurance and peace of mind to patients who have gone through a rigorous and often years-long process to receive a life-changing transplant.
![Fatigue](https://images.medicinenet.com//images/slideshow/12_causes_od_fatigue_s1_man_checking_cellphone_in_bed.jpg)
The development of this innovative implant represents a significant advancement in organ transplant medicine. The implant’s potential to revolutionize the monitoring of transplanted organs, along with its ease of use and minimal invasiveness, makes it an exciting prospect for transplant recipients worldwide.
Organ rejection is a challenging hurdle in organ transplantation, but this implant offers new hope. It paves the way for personalized medicine and tailored interventions that can improve patients’ long-term outcomes, giving them the best chance at a healthy life post-transplant. As researchers continue to refine and expand upon this technology, the future looks promising for organ transplantation and the well-being of transplant recipients.